Clinical Trial Update: Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update evaluating strategies to reduce graft-versus-host disease in donor blood stem cell transplant patients with acute leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndrome
• Myeloproliferative Neoplasm

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING